BMRN vs IEP · P/E 40, rev $1.76B vs rev $5.18B
Biomarin Pharmaceutical Inc (BMRN) versus Icahn Enterprises LP (IEP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Icahn Enterprises LP (IEP) is a oil & gas refining & marketing company listed on NASDAQ.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported IEP revenue for 2026-06-30 was $5.18B. Net income was -$814.0M. IEP currently screens at market cap $4.90B.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. IEP currently screens at market cap $4.90B.
Not investment advice. Open the BMRN and IEP stock pages for the full models.
Not investment advice.